The appointment was made as the company is preparing to launch its LifeGel flowable hemostat for spine surgery, according to a news release.
“He has helped to grow Raleigh Neurosurgical Clinic into one of the fastest-growing spine surgery center groups in the US,” Jim Buck, CEO of Medcura, said in the release.. “Given Medcura’s spine surgery focus as a market beachhead for LifeGel, Jacob is an outstanding addition and will provide expert insight guiding our commercialization of LifeGel into spine surgery centers and hospitals.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
